EP2746404
Efni gegn æxlum með forsögn um lækningaverkun fyrir sjúklinga með KRAS-stökkbreytt krabbamein í ristli og endaþarmi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
15.8.2012EP published:
6.12.2017EP application number:
12824342.5
EP translation filed:
31.1.2018Grant published:
15.2.2018EPO information:
European Patent Register
Max expiry date:
14.8.2032Expiry date:
14.8.2026Next due date:
31.8.2026
Title:
ANTITUMOR AGENT AND THERAPEUTIC EFFECT PREDICTION METHOD FOR PATIENTS WITH KRAS-MUTATED COLORECTAL CANCER
Timeline
Today
15.8.2012EP application
6.12.2017EP Publication
31.1.2018Translation submitted
15.2.2018Registration published
14.8.2026Expires
Owner
Name:
Taiho Pharmaceutical Co., Ltd.Address:
1-27, Kandanishiki-cho, 101-8444, Chiyoda-ku, Tokyo, JP
Inventor
Name:
ITO, MasanobuAddress:
Tokyo, JP
Name:
OKABE, HiroyukiAddress:
Tsukuba-shiIbaraki, JP
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
2011177838Date:
16.8.2011Country:
JP
Classification
Categories:
C12Q 1/68, A61K 31/513, A61K 31/7072, A61P 1/00, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 6.7.2018
Expires: 14.8.2019
Payer: Árnason Faktor
Number: 8
Paid: 9.7.2019
Expires: 14.8.2020
Payer: Árnason Faktor
Number: 9
Paid: 8.7.2020
Expires: 14.8.2021
Payer: Árnason Faktor ehf.
Number: 10
Paid: 12.7.2021
Expires: 14.8.2022
Payer: Árnason Faktor ehf.
Number: 11
Paid: 5.7.2022
Expires: 14.8.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 11.7.2023
Expires: 14.8.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 9.7.2024
Expires: 14.8.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 7.8.2025
Expires: 14.8.2026
Payer: Árnason Faktor ehf.